Stefano Partelli

Stefano Partelli
Profession:
Pancreatic surgeon
Languages:
EN
IT

Do you need an appointment?

Contact us and we will take care of you.
Secure your spot with the doctor
View doctor availability
Send request

Biography

Professor Stefano Partelli is Associate Professor of Surgery at Vita-Salute San Raffaele University and Senior Consultant at the Pancreatic and Transplant Surgery Unit of IRCCS Ospedale San Raffaele in Milan, directed by Professor Massimo Falconi.

After graduating in Medicine and Surgery (University of Verona, 2004) and specializing in General Surgery (University of Verona, 2010), he obtained a PhD in Surgical Sciences and Hepato-Biliary-Pancreatic Diseases (University of Verona, 2014). During his training, he carried out research and clinical activities abroad, including at the Royal London Hospital (Queen Mary University, UK), Massachusetts General Hospital (Boston, USA), and Memorial Sloan Kettering Cancer Center (New York, USA). In 2022, he was appointed Honorary Consultant at the Oxford Transplant Centre (Churchill Hospital, UK), and in 2025 Visiting Professor at the University of Toronto – Sunnybrook Hospital and the University of Texas Southwestern Medical Center.

Clinically, Prof. Partelli focuses primarily on pancreatic and transplant surgery, with particular expertise in:

  • Pancreatic neoplasms (adenocarcinoma, cystic and neuroendocrine tumors)
  • Inflammatory pancreatic diseases (acute and chronic pancreatitis)
  • Benign and malignant biliary tract diseases (gallstones, cholangiocarcinoma)
  • Neuroendocrine tumors (entero-pancreatic and adrenal)
  • Abdominal wall diseases (hernias and incisional hernias)
  • Kidney transplantation
  • Kidney and pancreas transplantation

His surgical experience includes over 1,000 general surgery procedures, among which more than 400 pancreatic resections, including vascular reconstructions and laparoscopic approaches.

He routinely performs minimally invasive procedures such as:

  • Distal pancreatectomy with or without splenectomy
  • Pancreatic enucleation
  • Central pancreatectomy
  • Cholecystectomy
  • Adrenalectomy

He is also a member of the multidisciplinary group for neuroendocrine tumors certified as an ENETS Center of Excellence since 2019, where he coordinates surgical activities.

In research, Prof. Partelli is Principal Investigator or Study Coordinator of numerous prospective clinical trials, including ASPEN, Neo.Lu.Pa.NET, BioSteP, and FIRENEN, and has presented his results as an invited speaker at over 100 national and international conferences.

He is the author of more than 290 publications (original articles, reviews, and editorials) indexed on PubMed, with an h-index of 52 and over 9,700 citations (Scopus, August 2025).

He is an active member of several scientific societies, including ENETS, ESSO, ESOT, E-AHPBA, EPC, SIC, AISP, and It.a.NET, where he serves on international scientific and educational committees.

Read moreRead less

Publications

Latest publications

Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting
Surg Endosc. 2020 Jan 17. doi: 10.1007/s00464-020-07375-0. [Epub ahead of print] PubMed PMID: 31953734.
Partelli S, Andreasi V, Rancoita PMV, Perez-Sanchez E, Muffatti F, Balzano G, Crippa S, Di Serio C, Falconi M.
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens
Neuroendocrinology. 2019;109(2):165-170. doi: 10.1159/000499606. Epub 2019 May 22. PubMed PMID: 31117106.
Partelli S, Giannone F, Schiavo Lena M,Muffatti F, Andreasi V, Crippa S, Tamburrino D, Zamboni G, Rubini C, Doglioni C, Falconi M
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life
Surgery. 2019 Aug;166(2):157-163. doi: 10.1016/j.surg.2019.04.003. Epub 2019 May 17. PubMed PMID: 31109657.
Partelli S, Mazza M, Andreasi V, Muffatti F, Crippa S, Tamburrino D, Falconi M.
Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma
Pancreas. 2019 Apr;48(4):504-509. doi: 10.1097/MPA.0000000000001273. PubMed PMID: 30946244.
Partelli S, Tamburrino D, Cherif R, Muffatti F, Moggia E, Gaujoux S, Sauvanet A, Falconi M, Fusai G.
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age
Dig Liver Dis. 2019 May;51(5):735-740. doi: 10.1016/j.dld.2019.01.008. Epub 2019 Jan 22. PubMed PMID: 30723019.
Partelli S, Muffatti F, Rancoita PMV, Andreasi V, Balzano G, Crippa S, Doglioni C, Rubini C, Zamboni G, Falconi M.
The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms
Eur J Surg Oncol. 2018 Jun;44(6):778-783. doi: 10.1016/j.ejso.2018.03.005. Epub 2018 Mar 17. PubMed PMID: 29610023.
Partelli S, Javed AA, Andreasi V, He J, Muffatti F, Weiss MJ, Sessa F, La Rosa S, Doglioni C, Zamboni G, Wolfgang CL, Falconi M.
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
Surgery. 2018 Apr;163(4):761-767. doi: 10.1016/j.surg.2017.11.007. Epub 2017 Dec 25. PubMed PMID: 29284590.
Partelli S, Bertani E, Bartolomei M, Perali C, Muffatti F, Grana CM, Schiavo Lena M, Doglioni C, Crippa S, Fazio N, Zamboni G, Falconi M.
Early Postoperative Prediction of Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: usefulness of C-reactive Protein
HPB (Oxford). 2017 Jul;19(7):580-586. doi: 10.1016/j.hpb.2017.03.001. Epub 2017 Apr 7. PubMed PMID: 28392159.
Partelli S, Pecorelli N, Muffatti F, Belfiori G, Crippa S, Piazzai F, Castoldi R, Marmorale C, Balzano G, Falconi M.
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
Ruszniewski P, Scoazec JY, Toumpanakis C, Kianmanesh R, Falconi M; Antibes Consensus Conference participants. Neuroendocrinology. 2017;105(3):255-265. doi: 10.1159/000464292. Epub 2017 Feb 25. PubMed PMID: 28237989.
Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, Nieveen van Dijkum EJM, Pape UF, Pascher A, Ramage J, Reed N,
Whole-genome landscape of pancreatic neuroendocrine tumours
Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15. Erratum in: Nature. 2017 Sep 27;:. PubMed PMID: 28199314.
58: Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davì MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM.
Evaluation of an enhanced recovery protocol after pancreaticoduodenectomy in elderly patients
HPB (Oxford). 2016 Feb;18(2):153-158. doi: 10.1016/j.hpb.2015.09.009. Epub 2015 Dec 10. PubMed PMID: 26902134; PubMed Central PMCID: PMC4814589.
Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch DK, Falconi M. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg. 2017 Jan;104(1):34-41. doi: 10.1002/bjs.10312. Epub 2016 Oct 5. Review. PubMed PMID: 27706803. Partelli S, Crippa S, Castagnani R, Ruffo G, Marmorale C, Franconi AM, De Angelis C, Falconi M.
Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)
JAMA Surg. 2013 Oct;148(10):932-9. doi: 10.1001/jamasurg.2013.3376. PubMed PMID: 23986355.
Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, Scarpa A, Ruszniewski P, Sauvanet A, Falconi M.
Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection
Ann Surg Oncol. 2011 Dec;18(13):3608-14. doi: 10.1245/s10434-011-1769-1. Epub 2011 May 17. PubMed PMID: 21584836.
Partelli S, Crippa S, Barugola G, Tamburrino D, Capelli P, D'Onofrio M, Pederzoli P, Falconi M.
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio
Ann Surg. 2010 Mar;251(3):477-82. doi: 10.1097/SLA.0b013e3181cf9155. PubMed PMID: 20142730; PubMed Central PMCID: PMC3135381.
Partelli S, Fernandez-Del Castillo C, Bassi C, Mantovani W, Thayer SP, Crippa S, Ferrone CR, Falconi M, Pederzoli P, Warshaw AL, Salvia R.